Myriad Genetics has entered into a definitive agreement to acquire inflammatory and autoimmune diagnostics company Crescendo Bioscience for $270 million.
Law firm Baker & McKenzie has hired pharmaceutical lawyer Julian Thurston as a consultant in its global pharmaceutical and healthcare industry group.
UK IP law firm Powell Gilbert has appointed solicitor and medical doctor Tess Waldron as an associate.
A US medical research foundation has received about $131.2 million in damages after a jury found that two of its patents covering cochlear implants were infringed.
Healthcare company Covidien PLC has been told it did not infringe patents belonging to a Johnson & Johnson-owned company through using its ultrasonic dissection device.
On January 28, Teva announced that the FDA had approved its supplemental new drug application for a new formulation of its biggest selling drug Copaxone.
The UK High Court has decided to award Slovenian generic pharmaceutical company KRKA damages after a preliminary injunction enforced against the company by AstraZeneca was discharged.
Law firm Blank Rome LLP has expanded its IP litigation group with the appointment of Christopher Hu.
Johnson & Johnson has been named the most effective pharmaceutical company on social media, in a new report.
A government-appointed panel in India is preparing to evaluate more patented drugs for local generic pharmaceutical companies to mimic, according to reports.